Literature DB >> 18157671

Trends in the consumption of opioid analgesics in Spain. Higher increases as fentanyl replaces morphine.

Javier Garcia del Pozo1, Alfonso Carvajal, Jose Maria Viloria, Alfonso Velasco, Victorina Garcia del Pozo.   

Abstract

OBJECTIVE: During the past few years there have been changes in the availability of opioids in Spain, and new policies on palliative care have been implemented. The aim of this study was to describe the new pattern of opioid consumption in Spain and the associated economic impact.
METHODS: A search in the ECOM (Especialidades Consumo de Medicamentos) database of the Ministry of Health and Consumer Affairs for the 1992-2006 period was carried out. This database contains information on prescriptions of primary care medicines that are covered by the National Health System in Spain.
RESULTS: Since 1992, overall opioid consumption has increased 14-fold, from 0.3 DDD/1000 inhabitants per day to 4.4 DDD/1000 inhabitants per day. For the six drugs that require a special prescription form--morphine, methadone, oxycodone pethidine, tilidine and fentanyl--consumption increased from 0.1 DDD/1000 inhabitants per day in 1992 to 1.2 in 2006. During this same period, the total costs of these prescriptions increased by 36.8-fold, and the cost per day and per patient doubled.
CONCLUSION: A huge increase in opioid consumption has occurred during the time period covered by this study, with fentanyl consumption accounting for most of that increase. Although oral morphine is the first-choice drug among strong opioids, fentanyl is currently the most consumed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18157671     DOI: 10.1007/s00228-007-0419-9

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  9 in total

1.  Report from Spain.

Authors:  D Gracia; J M Nuñez Olarte
Journal:  Support Care Cancer       Date:  2000-05       Impact factor: 3.603

2.  Opioid consumption in Spain--the significance of a regulatory measure.

Authors:  J García del Pozo; A Carvajal; A M Rueda de Castro; M I Cano del Pozo; L H Martín Arias
Journal:  Eur J Clin Pharmacol       Date:  1999-11       Impact factor: 2.953

3.  Opioid prescription in Italy: new law, no effect.

Authors:  Sebastiano Mercadante
Journal:  Lancet       Date:  2002-10-19       Impact factor: 79.321

4.  Opioids in Italy: is marketing more powerful than the law?

Authors:  Alessandro Chinellato; Gianni Terrazzani; Tom Walley; Pietro Giusti
Journal:  Lancet       Date:  2003-07-05       Impact factor: 79.321

5.  Opioid consumption in Italy: industry is not necessarily business--look at the effects.

Authors:  Sebastiano Mercadante
Journal:  J Pain Symptom Manage       Date:  2004-05       Impact factor: 3.612

6.  Trends in consumption of opioid analgesics in Slovak Republic during 1998-2002.

Authors:  R Hudec; J Tisonová; L Bozeková; V Foltán
Journal:  Eur J Clin Pharmacol       Date:  2004-07-01       Impact factor: 2.953

Review 7.  Principles of control of cancer pain.

Authors:  Marie Fallon; Geoffrey Hanks; Nathan Cherny
Journal:  BMJ       Date:  2006-04-29

8.  Retrospective analysis of opioid prescriptions in cancer patients in a northern Italian region.

Authors:  Alessandro Chinellato; Gianni Terrazzani; Patrizia Debetto; Paola Zambon; Stefano Guzzinati; Tom Walley; Pietro Giusti
Journal:  Br J Clin Pharmacol       Date:  2006-07       Impact factor: 4.335

9.  [Calculation of the number of terminally ill patients through their use of opioid analgesics and tumor mortality].

Authors:  E Escortell-Mayor; O Larrubia-Muñoz; D Troncoso-Viejo; R Martínez-Martínez; A López-Romero; C de Miguel-Sánchez
Journal:  Aten Primaria       Date:  2006-02-15       Impact factor: 1.137

  9 in total
  24 in total

Review 1.  [Use of prescription drugs in Spain and Europe].

Authors:  Juan Simó Miñana
Journal:  Aten Primaria       Date:  2011-10-22       Impact factor: 1.137

2.  The association between prescribed opioid use for mothers and children: a record-linkage study.

Authors:  Tomas Log; Svetlana Skurtveit; Randi Selmer; Aage Tverdal; Kari Furu; Ingeborg Hartz
Journal:  Eur J Clin Pharmacol       Date:  2012-06-09       Impact factor: 2.953

3.  Efficacy and tolerability of oxycodone in moderate-severe cancer-related pain: A meta-analysis of randomized controlled trials.

Authors:  Yu-Mei Wang; Zu-Wang Liu; Jia-Li Liu; Lei Zhang
Journal:  Exp Ther Med       Date:  2010-05-10       Impact factor: 2.447

4.  Use of prescribed opioid analgesics and co-medication with benzodiazepines in women before, during, and after pregnancy: a population-based cohort study.

Authors:  Marte Handal; Anders Engeland; Marit Rønning; Svetlana Skurtveit; Kari Furu
Journal:  Eur J Clin Pharmacol       Date:  2011-04-12       Impact factor: 2.953

5.  Trends in opioid analgesics consumption, Israel, 2000-2008.

Authors:  Alexander M Ponizovsky; Eli Marom; Alexander Zeldin; Nathan I Cherny
Journal:  Eur J Clin Pharmacol       Date:  2010-11-06       Impact factor: 2.953

6.  The Contemporary American Drug Overdose Epidemic in International Perspective.

Authors:  Jessica Y Ho
Journal:  Popul Dev Rev       Date:  2019-02-20

7.  Trends in analgesic consumption in France over the last 10 years and comparison of patterns across Europe.

Authors:  Karima Hider-Mlynarz; Philippe Cavalié; Patrick Maison
Journal:  Br J Clin Pharmacol       Date:  2018-04-02       Impact factor: 4.335

Review 8.  Pain treatment with opioids : achieving the minimal effective and the minimal interacting dose.

Authors:  Pierangelo Geppetti; Silvia Benemei
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

9.  Self-reported practices in opioid management of chronic noncancer pain: a survey of Canadian family physicians.

Authors:  Michael John Maynard Allen; Mark M Asbridge; Peter C Macdougall; Andrea D Furlan; Oleg Tugalev
Journal:  Pain Res Manag       Date:  2013-05-28       Impact factor: 3.037

Review 10.  An overview of the patterns of prescription opioid use, costs and related harms in Australia.

Authors:  Bianca Blanch; Sallie-Anne Pearson; Paul S Haber
Journal:  Br J Clin Pharmacol       Date:  2014-11       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.